secwatch.observer — SEC 8-K summary
======================================

Issuer:     IR-Med, Inc. (—)
CIK:        0001839133
Form:       8-K
Filed at:   2023-10-04T23:59:59+00:00
Accession:  0001493152-23-035696
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

IR-Med appoints healthcare exec Tzur Di-Cori as CEO; PressureSafe commercial launch pending approval
--------------------------------------------------------------------------------

- Tzur Di-Cori appointed CEO effective Oct 15, 2023; previously President/CEO of LifeWatch Technologies and other healthcare firms.
- Receives monthly salary of NIS 45,000 (~$11,842) and options for 1,000,000 shares at $0.58, vesting over 4 years.
- Chairman Oded Bashan remains Chairman; commercial launch of PressureSafe expected in current quarter pending regulatory approval.
- Di-Cori's previous roles include CEO of Motorika Medical, Veoli, DUSMIT; no family relationships with directors.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1839133/000149315223035696/0001493152-23-035696-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1839133/000149315223035696/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-035696

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer